Predict your next investment

Investment Bank
FINANCIAL
daiwa-grp.jp

See what CB Insights has to offer

Investments

12

Portfolio Exits

2

Funds

2

Partners & Customers

4

About Daiwa Securities Group

Daiwa Securities Group (TYO: 8601) is a comprehensive financial service firm that operates core businesses such as Retail, Global Markets, Global Investment Banking, Asset Management, and Investment.

Daiwa Securities Group Headquarter Location

GranTokyo North Tower 9-1, Marunouchi 1-chome, Chiyoda-ku

Tokyo, 100-6751,

Japan

+81-3-5555-1111

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Daiwa Securities Group Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Daiwa Securities Group Rank

Latest Daiwa Securities Group News

Elixiron Immunotherapeutics Closes $27M Series A-1 Financing Round

Aug 23, 2021

Elixiron Immunotherapeutics, Inc. , a company developing therapeutics for cancer, neurological diseases and inflammatory disorders, closed a $27m Series A-1 extension financing round, bringing the total Series A-1 raise to $27m. The round was jointly led by Pangu Capital (a new investor) and Taiwania Capital (an existing investor) and was joined by further new investors, including DCI Partners of Daiwa Securities Group, Mega International Commercial Bank, Fubon Financial Holdings and Hong Tai Electric Industrial, as well as other existing investors such as China Development Capital Industrial Bank (CDIB) Capital Group. Founded in 2017 and led by Hung-Kai Chen, Founder, CEO and Chairman of the Board, Elixiron is a biotechnology company with operations in San Francisco, Taipei and Shanghai on a mission to develop next-generation immunotherapies for neurodegenerative and immunological disorders, as well as cancer, by tapping into what human clinical findings can teach us for reverse-translational medicine approaches. The company intends to use the funds to advance phase 1 trials of two pipeline candidates and take three immuno-oncology assets towards IND applications. EI-1071 is an orally available, highly potent Colony-Stimulating Factor 1 Receptor inhibitor that is in a phase 1 trial in part thanks to an Alzheimer’s Association Part the Cloud-Gates Partnership Grant Program award. EI-001 is a fully human antibody that neutralizes an immuno-modulatory target of interest in Vitiligo and some other immunological disorders including Chronic Hepatitis B. The executive team includes: Pandelakis Koni, Executive Vice President of R&D, formerly Director of Research at the Parker Institute for Cancer Immunotherapy, and Carrie Duan, Executive Vice President of Clinical Development, who previously had leading roles in clinical development and medical affairs management with AstraZeneca, Bayer, GSK and other multinational companies. FinSMEs 23/08/2021

Daiwa Securities Group Investments

12 Investments

Daiwa Securities Group has made 12 investments. Their latest investment was in SiCepat as part of their Series B - III on March 3, 2021.

CBI Logo

Daiwa Securities Group Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/5/2021

Series B - III

SiCepat

$120M

Yes

4

3/2/2020

Convertible Note

Global X

$120M

Yes

1

1/30/2020

Unattributed

Katana Marketing

$128M

Yes

2

10/31/2019

Series A

Subscribe to see more

$99M

Subscribe to see more

10

9/30/2019

Seed - V

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/5/2021

3/2/2020

1/30/2020

10/31/2019

9/30/2019

Round

Series B - III

Convertible Note

Unattributed

Series A

Seed - V

Company

SiCepat

Global X

Katana Marketing

Subscribe to see more

Subscribe to see more

Amount

$120M

$120M

$128M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

1

2

10

10

Daiwa Securities Group Portfolio Exits

2 Portfolio Exits

Daiwa Securities Group has 2 portfolio exits. Their latest portfolio exit was Enechange on December 23, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/23/2020

IPO

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

12/23/2020

00/00/0000

Exit

IPO

Subscribe to see more

Companies

Subscribe to see more

Valuation

Acquirer

Subscribe to see more

Sources

10

Daiwa Securities Group Acquisitions

3 Acquisitions

Daiwa Securities Group acquired 3 companies. Their latest acquisition was Fintertech on March 05, 2018.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

3/5/2018

Spinoff / Spinout

1

7/27/2017

Subscribe to see more

$99M

Subscribe to see more

10

7/27/2017

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/5/2018

7/27/2017

7/27/2017

Investment Stage

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

Total Funding

$99M

$99M

Note

Spinoff / Spinout

Subscribe to see more

Subscribe to see more

Sources

1

10

10

Daiwa Securities Group Fund History

2 Fund Histories

Daiwa Securities Group has 2 funds, including Daiwa Myanmar Growth Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

7/12/2012

Daiwa Myanmar Growth Fund

$30M

1

Daiwa Securities Group-Sony Venture Capital Fund

Subscribe to see more

$99M

10

Closing Date

7/12/2012

Fund

Daiwa Myanmar Growth Fund

Daiwa Securities Group-Sony Venture Capital Fund

Fund Type

Subscribe to see more

Status

Amount

$30M

$99M

Sources

1

10

Daiwa Securities Group Partners & Customers

4 Partners and customers

Daiwa Securities Group has 4 strategic partners and customers. Daiwa Securities Group recently partnered with Japan Post on May 5, 2019.

Date

Type

Business Partner

Country

News Snippet

Sources

5/14/2019

Partner

Japan Post

Japan

Japan Post taps Daiwa to boost fee revenue

TOKYO -- Japan Post will partner with Daiwa Securities Group to create new investment products , seeking additional fee revenue for its banking unit to shore up profits eroded by years of low interest rates , Nikkei has learned .

1

11/25/2015

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

10/22/2015

Client

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

4/6/2012

Vendor

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

5/14/2019

11/25/2015

10/22/2015

4/6/2012

Type

Partner

Partner

Client

Vendor

Business Partner

Japan Post

Country

Japan

Subscribe to see more

Subscribe to see more

Subscribe to see more

News Snippet

Japan Post taps Daiwa to boost fee revenue

TOKYO -- Japan Post will partner with Daiwa Securities Group to create new investment products , seeking additional fee revenue for its banking unit to shore up profits eroded by years of low interest rates , Nikkei has learned .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

Daiwa Securities Group Team

2 Team Members

Daiwa Securities Group has 2 team members, including former Chief Administrative Officer, KimSiam Teo.

Name

Work History

Title

Status

KimSiam Teo

StarHub, and Sony

Chief Administrative Officer

Former

Harold Gartner

Senior Vice President

Former

Name

KimSiam Teo

Harold Gartner

Work History

StarHub, and Sony

Title

Chief Administrative Officer

Senior Vice President

Status

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.